Stockscreener 앱 받기
52.10
1.70%
-0.90
시장 영업 전:
52.10
Exelixis Inc 주식(EXEL)의 최신 뉴스
Exelixis Inc Stock (US30161Q1040): Quarterly earnings in focus after recent results - AD HOC NEWS
Why (EXEL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Exelixis CABINET Win Extends CABOMETYX Reach And Raises Valuation Questions - Yahoo Finance Singapore
Exelixis, Inc. (EXEL) stock price, news, quote and history - Yahoo Finance UK
Exelixis, Inc. (EXEL) Latest Stock News & Headlines - Yahoo Finance
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight - GlobeNewswire Inc.
Exelixis Hits High on Growing Sales, Institutional Inflows - Yahoo Finance
Goldman Sachs Group Inc. Purchases 1,113,916 Shares of Exelixis, Inc. $EXEL - MarketBeat
Cibc World Market Inc. Purchases 31,985 Shares of Exelixis, Inc. $EXEL - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Has $1.91 Million Position in Exelixis, Inc. $EXEL - MarketBeat
Exelixis Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Exelixis stock hits all-time high at 52.98 USD By Investing.com - Investing.com Canada
Exelixis stock hits all-time high at 52.98 USD - Investing.com
Exelixis Inc (NASDAQ:EXEL) Offers Decent Value with Strong Profitability and Financial Health - ChartMill
Bank of New York Mellon Corp Cuts Position in Exelixis, Inc. $EXEL - MarketBeat
· Analyst Forecast - MLQ.ai
Exelixis, Inc. $EXEL Position Increased by Northwestern Mutual Wealth Management Co. - MarketBeat
Exelixis, Inc. (EXEL) Stock Analysis: A Promising Player in Biotechnology with Strong Revenue Growth - DirectorsTalk Interviews
Los Angeles Capital Management LLC Has $49.57 Million Holdings in Exelixis, Inc. $EXEL - MarketBeat
Commonwealth Equity Services LLC Sells 259,643 Shares of Exelixis, Inc. $EXEL - MarketBeat
168,437 Shares in Exelixis, Inc. $EXEL Purchased by WINTON GROUP Ltd - MarketBeat
Norges Bank Makes New Investment in Exelixis, Inc. $EXEL - MarketBeat
EULAV Asset Management Trims Stock Position in Exelixis, Inc. $EXEL - MarketBeat
CABINET Results Broaden CABOMETYX Neuroendocrine Reach And Investor Considerations - Sahm
Exelixis (NASDAQ:EXEL) Reaches New 52-Week HighTime to Buy? - MarketBeat
Why Exelixis (EXEL) is a top growth stock for the long term - MSN
Exelixis, Inc. (EXEL) latest stock news and headlines - Yahoo Finance UK
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History - Yahoo Finance
Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
Marietta Investment Partners LLC Has $815,000 Stock Holdings in Exelixis, Inc. $EXEL - MarketBeat
EXEL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Understanding Momentum Shifts in (EXEL) - Stock Traders Daily
Insider Sell Alert: Jack Wyszomierski Sells 3,925 Shares of Exelixis Inc (EXEL) - GuruFocus
Exelixis Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Exelixis director Jack Wyszomierski sells $198,408 in shares By Investing.com - Investing.com Australia
Exelixis director Jack Wyszomierski sells $198,408 in shares - Investing.com UK
Exelixis director Sue Eckhardt sells $491,973 in stock - Investing.com UK
Exelixis director Sue Eckhardt sells $491,973 in stock By Investing.com - Investing.com Australia
Planned share sale by Exelixis (NASDAQ: EXEL) director Wyszomierski - Stock Titan
Exelixis (EXEL) director Eckhardt sells 9,812 shares under 10b5-1 plan - Stock Titan
Exelixis Jumps 5.0% Amid Sector-Wide Rally - AlphaStreet
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance
Exelixis, Inc. $EXEL Shares Purchased by BNP Paribas Financial Markets - MarketBeat
If Decades of History Tell Us Anything, This Biotech Near $50 Is Primed to Skyrocket - AOL.com
Legal & General Group Plc Sells 110,542 Shares of Exelixis, Inc. $EXEL - MarketBeat
HighTower Advisors LLC Decreases Position in Exelixis, Inc. $EXEL - MarketBeat
Geode Capital Management LLC Sells 141,796 Shares of Exelixis, Inc. $EXEL - MarketBeat
[144] EXELIXIS, INC. SEC Filing - Stock Titan
Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strong Analyst Support - DirectorsTalk Interviews
Exelixis (EXEL) Reports Positive Phase 3 Trial Results for Cabom - GuruFocus
1.27%
1.43%
자본화:
|
볼륨(24시간):